898 related articles for article (PubMed ID: 16729877)
1. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
2. How different are luminal A and basal breast cancers?
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Buttarelli M; Jacquemier J; Chaffanet M; Maraninchi D; Viens P; Birnbaum D
Int J Cancer; 2009 Mar; 124(6):1338-48. PubMed ID: 19058218
[TBL] [Abstract][Full Text] [Related]
3. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
4. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
6. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
[TBL] [Abstract][Full Text] [Related]
7. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
Finetti P; Cervera N; Charafe-Jauffret E; Chabannon C; Charpin C; Chaffanet M; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Cancer Res; 2008 Feb; 68(3):767-76. PubMed ID: 18245477
[TBL] [Abstract][Full Text] [Related]
8. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
[TBL] [Abstract][Full Text] [Related]
9. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
10. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
11. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.
Perreard L; Fan C; Quackenbush JF; Mullins M; Gauthier NP; Nelson E; Mone M; Hansen H; Buys SS; Rasmussen K; Orrico AR; Dreher D; Walters R; Parker J; Hu Z; He X; Palazzo JP; Olopade OI; Szabo A; Perou CM; Bernard PS
Breast Cancer Res; 2006; 8(2):R23. PubMed ID: 16626501
[TBL] [Abstract][Full Text] [Related]
12. Gene expression patterns associated with p53 status in breast cancer.
Troester MA; Herschkowitz JI; Oh DS; He X; Hoadley KA; Barbier CS; Perou CM
BMC Cancer; 2006 Dec; 6():276. PubMed ID: 17150101
[TBL] [Abstract][Full Text] [Related]
13. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
Gene; 2022 May; 821():146328. PubMed ID: 35181505
[TBL] [Abstract][Full Text] [Related]
14. Repeated observation of breast tumor subtypes in independent gene expression data sets.
Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lønning PE; Brown PO; Børresen-Dale AL; Botstein D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8418-23. PubMed ID: 12829800
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of breast cell lines identifies potential new basal markers.
Charafe-Jauffret E; Ginestier C; Monville F; Finetti P; Adélaïde J; Cervera N; Fekairi S; Xerri L; Jacquemier J; Birnbaum D; Bertucci F
Oncogene; 2006 Apr; 25(15):2273-84. PubMed ID: 16288205
[TBL] [Abstract][Full Text] [Related]
16. FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.
Horton JK; Siamakpour-Reihani S; Lee CT; Zhou Y; Chen W; Geradts J; Fels DR; Hoang P; Ashcraft KA; Groth J; Kung HN; Dewhirst MW; Chi JT
Radiat Res; 2015 Nov; 184(5):456-69. PubMed ID: 26488758
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
19. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
